NCT04855604

Brief Summary

A cross-sectional study is expected to conducted by inquiring about the history, diagnosis results and medication details of respiratory diseases of the outpatient pediatric patients with respiratory diseases in the pediatric departments at specialist children's hospital at the second class and above, general hospitals and maternal and child healthcare hospitals. About 10,000 electronic questionnaires are expected to be collected in total, with about 100 participating hospitals and 100 electronic questionnaires from each participating hospital.Diagnosis and treatment information of pediatric patients are expected to be collected in the third week in April, July and October 2021 and in January 2022.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 20, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

April 20, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 22, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2022

Completed
Last Updated

April 22, 2021

Status Verified

April 1, 2021

Enrollment Period

10 months

First QC Date

April 20, 2021

Last Update Submit

April 20, 2021

Conditions

Keywords

respiratory diseasestreatmentmedicationchildren

Outcome Measures

Primary Outcomes (1)

  • General information of pediatric patients

    General information of pediatric patients

    1 year

Secondary Outcomes (2)

  • History of respiratory diseases and medication of pediatric patients in the past year

    1 year

  • Diagnosis and medication information of pediatric patients in the Study

    1 year

Eligibility Criteria

Age1 Day - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

All children aged between 0-14 years, and diagnosed with respiratory disease can be enrolled in our study with their (or their parents') agreements.

You may qualify if:

  • All children participating in this clinical study must meet all of the following criteria.
  • age: 0-14 years old, male and female;
  • accord with diagnostic criteria of respiratory diseases
  • Agreed to informed consent

You may not qualify if:

  • All children with any of the following conditions must be excluded from this study:
  • children who visit hospital duo to discharge of hospital
  • Children who visit hospital beyond 2 times in 7 days.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baoping Xu

Beijing, Beijing Municipality, 100045, China

RECRUITING

MeSH Terms

Conditions

Respiratory Tract Diseases

Central Study Contacts

Baoping Xu, MD,PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of Respiratory Department Affiliation: Beijing Children's Hospital

Study Record Dates

First Submitted

April 20, 2021

First Posted

April 22, 2021

Study Start

April 20, 2021

Primary Completion

January 30, 2022

Study Completion

January 30, 2022

Last Updated

April 22, 2021

Record last verified: 2021-04

Locations